{
  "report_rows": [
    {
      "kpi": "Q2 2026 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.97B vs. cons $1.94B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 pro forma EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.37 vs. cons $2.29",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 operating margin",
      "prediction": "IN-LINE",
      "answer": "pred ~25.7% vs. cons 25.5%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Revenue guidance",
      "prediction": "BETTER",
      "answer": "guide ~$8.00B vs. cons $7.99B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Pro forma EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$9.60 vs. cons $9.58 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating margin guidance",
      "prediction": "BETTER",
      "answer": "guide ~25.7% vs. cons 25.6% (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -2.2,
  "day1_confidence": "LOW",
  "day5_residual_pct": -3.8,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A Q2 EPS beat of ~$2.37 vs. cons $2.29 is likely offset by FY2026 guidance of ~$9.60 vs. cons $9.58, implying H2 EPS of only ~$5.15 vs. pre-print cons ~$5.21; the resulting out-period estimate cuts should extend the initial weakness.",
  "day5_confidence": "MEDIUM"
}